Drug Discovery
SP launches SP Hull LyoStar(R) 4.0 to enhance speed to market in drug development
New advanced pilot-scale lyophilizer supports rapid and highly effective freezedry cycle development, optimization and process scale-up Based on a...
June 23, 2021 | News
Eurofins Discovery Expand their Antibody Discovery Platform
Eurofins Discovery's global clients will have access to ImmunoPrecise's end-to-end antibody discovery capabilities using wild type and best-in-class i...
June 23, 2021 | News
Australia's Viraleze™ is highly effective against Alpha, Beta and Gamma COVID variants
The results from the renowned Scripps Research Institute in the US confirm that SPL7013, the active ingredient in Viraleze™, is highly acti...
June 18, 2021 | News
Gilead Sciences committed to Global Elimination of Hepatitis C
Data Presented at the Global Hepatitis Summit Show that Virally Suppressed Patients from Taiwan with Renal or Hepatic Impairment had High Rates of Vi...
June 18, 2021 | News
Debiopharm and Ubix Therapeutics o Develop a New Anti-Cancer Modality -
Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company and Ubix Therapeutics (en.ubixtrx.com), a South Korea-based biotech co...
June 17, 2021 | News
With Serum Institute as a partner, Novavax is poised to launch in India.
The Novavax trials conducted on 29,960 people in the US and Mexico have delivered results that equal the Pfizer NSE -1.09 % and Moderna jabs and do better ...
June 16, 2021 | News
Harbour BioMed and Dana-Farber to Advance Novel Biotherapies for Cancer Treatment
Harbour BioMed scientists and Dana-Farber researchers will be working together to develop novel oncologic drugs, including bispecific antibodies and CAR-T ...
June 16, 2021 | News
Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy
93% efficacy against predominantly circulating Variants of Concern and Variants of Interest 91% efficacy in high-risk populations 100% efficacy against...
June 15, 2021 | News
VERAXA Biotech and Quadira Biosciences Enter Partnership on ADC Development
The collaboration will leverage both the advantages of VERAXA's advanced and proprietary position-true click-chemistry-based drug conjugation technology in...
June 14, 2021 | News
FDA Takes Steps to Increase Availability of COVID-19 Vaccine
The agency is announcing today that it is authorizing for use, under the emergency use authorization (EUA) for the Janssen COVID-19 vaccine, two batches of...
June 12, 2021 | News
PerkinElmer to help speed drug discovery
Leading academic, research and industry group led by Broad Institute to help speed drug discovery PerkinElmer, Inc., a global leader committed to ...
June 11, 2021 | News
FDA’s Decision to Approve New Treatment for Alzheimer’s Disease
This approval is significant in many ways. Aduhelm is the first novel therapy approved for Alzheimer’s disease since 2003. Perhaps more significantly...
June 09, 2021 | News | By Dr. Patrizia Cavazzoni, Director, FDA Center for Drug Evaluation and Research
Merck’s KEYTRUDA® Given After Surgery Reduced the Risk of Disease Recurrence or Death
First-Time Disease-Free Survival Data to be Presented During Plenary Session at the 2021 ASCO Annual Meeting Merck’s KEYTRUDA® (pemb...
June 07, 2021 | News
Samsung Pharm & GemVax present pancreatic cancer immunotherapeutic drug, RIAVAX™
ASCO 2021, which celebrates its 57th anniversary this year, runs from June 4th to June 8th and will be held virtually due to COVID-19. Some ...
June 07, 2021 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
